Crispr Therapeutics Q3 Earnings: No Casgevy Revenue, But Plenty Of Optimism
Crispr has already secured a historic first approval for a CRISPR/Cas9 drug and has several more potential blockbuster ...
Genome Editing Market Expected To Reach 30.78 Billion 2032, Growing at CAGR 17.18% | Introspective Market Research
Genome Editing Market Size Was Valued at USD 7.39 Billion in 2023, and is Projected to Reach USD 30.78 Billion by 2032, ...
Orsini Now Distributing CASGEVY® (exagamglogene autotemcel), a Gene-Editing Therapy
Orsini has been chosen by Vertex Pharmaceuticals Incorporated to dispense gene-editing therapy CASGEVY® (exagamglogene ...
The Jerusalem Post Blogs1d
Gene-edited tomatoes achieve increased sweetness without loss of size or yield
In a groundbreaking study published in the journal Nature, researchers have successfully used gene editing to create sweeter ...
Singularity Hub1d
Sweet CRISPR Tomatoes May Be Coming to a Supermarket Near You
Using CRISPR, the popular gene-editing tool, scientists bumped up the fruit’s sugar content by 30 percent without sacrificing ...
ZME Science1d
New study using CRISPR technology reveals a way to make tomatoes sweeter without sacrificing yield.
They realized that if they “release” these breaks, tomatoes could become much sweeter. They used CRISPR-Cas9 gene-editing ...
CRISPR Therapeutics to Present at the Jefferies London Healthcare Conference
CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for ...
Gene therapy protects against motor neuron disease in rats
University of Wisconsin–Madison researchers targeting a group of hereditary neurodegenerative diseases have found success ...
Nature3d
CRISPR builds a big tomato that’s actually sweet
Rotten tomatoes no more: growing sweeter tomatoes is possible by editing just two of the fruit’s genes. Deleting the genes ...
RNA editing promises to go where DNA editing can’t
On October 16, a biotechnology company in Massachusetts in the U.S. named Wave Life Sciences made headlines for becoming the ...
Managed Healthcare Executive2d
A Single CRISPR Treatment Could Replace a Lifetime of Daily Treatment in Hereditary Angioedema
In a phase 2 trial, a gene therapy reduced angioedema attacks, which could significantly change the quality of life for ...
Frontiers13d
CRISPR/Cas9 in Cancer: Pioneering Gene Editing for Enhanced Drug Discovery
Cancer continues to be a formidable challenge globally, with traditional drug discovery methods focusing on cytotoxic agents and targeted therapies altering the landscape of cancer prognosis and ...